Accumulate Clean Science and Technology; target of Rs 769: Prabhudas Lilladher

Moneycontrol • 1 day ago

Original source

Key Investment Pillars

  • The HALS segment is expected to drive growth, with a 2x YoY revenue increase in Q2FY27, supported by strong volume ramp-up.
  • Improving capacity utilization, with a target of 55-60% over the coming quarters, is expected to enhance margins.
  • The commercialization of Performance Chemicals II in Q4FY27 and the launch of advanced-grade HALS products are expected to provide medium-term growth opportunities.
  • Elevated raw material costs and lower Chinese pricing are restricting the company's ability to pass on cost increases, resulting in margin moderation.

Thesis Validation Checklist

  • Investors should watch for signs of improving capacity utilization, particularly in the HALS segment, and the successful commercialization of new products.
  • Margin expansion, driven by improving operating leverage and cost discipline, will be crucial in validating the thesis.
  • The company's ability to navigate raw material cost pressures and maintain its pricing power will be important in determining the stock's performance.
  • Progress on the Geneus collaboration and the export mix will also be key indicators of the company's growth prospects.